1. Home
  2. SILO vs APVO Comparison

SILO vs APVO Comparison

Compare SILO & APVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SILO
  • APVO
  • Stock Information
  • Founded
  • SILO 2010
  • APVO 2016
  • Country
  • SILO United States
  • APVO United States
  • Employees
  • SILO N/A
  • APVO N/A
  • Industry
  • SILO Apparel
  • APVO Biotechnology: Pharmaceutical Preparations
  • Sector
  • SILO Consumer Discretionary
  • APVO Health Care
  • Exchange
  • SILO Nasdaq
  • APVO Nasdaq
  • Market Cap
  • SILO 8.8M
  • APVO 6.5M
  • IPO Year
  • SILO N/A
  • APVO N/A
  • Fundamental
  • Price
  • SILO $1.61
  • APVO $4.16
  • Analyst Decision
  • SILO
  • APVO Strong Buy
  • Analyst Count
  • SILO 0
  • APVO 1
  • Target Price
  • SILO N/A
  • APVO $296.00
  • AVG Volume (30 Days)
  • SILO 9.1M
  • APVO 47.2K
  • Earning Date
  • SILO 02-14-2025
  • APVO 03-04-2025
  • Dividend Yield
  • SILO N/A
  • APVO N/A
  • EPS Growth
  • SILO N/A
  • APVO N/A
  • EPS
  • SILO N/A
  • APVO N/A
  • Revenue
  • SILO $72,102.00
  • APVO N/A
  • Revenue This Year
  • SILO $1.86
  • APVO N/A
  • Revenue Next Year
  • SILO N/A
  • APVO N/A
  • P/E Ratio
  • SILO N/A
  • APVO N/A
  • Revenue Growth
  • SILO N/A
  • APVO N/A
  • 52 Week Low
  • SILO $0.77
  • APVO $3.65
  • 52 Week High
  • SILO $4.50
  • APVO $399.60
  • Technical
  • Relative Strength Index (RSI)
  • SILO 52.57
  • APVO 39.61
  • Support Level
  • SILO $1.56
  • APVO $3.77
  • Resistance Level
  • SILO $1.89
  • APVO $4.47
  • Average True Range (ATR)
  • SILO 0.19
  • APVO 0.29
  • MACD
  • SILO -0.05
  • APVO 0.08
  • Stochastic Oscillator
  • SILO 27.12
  • APVO 38.40

About SILO Silo Pharma Inc.

SILO Pharma Inc is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The company's lead program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders.

About APVO Aptevo Therapeutics Inc.

Aptevo Therapeutics Inc is a clinical-stage, research and development biotechnology company focused on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. Its clinical candidate, APVO436, and preclinical candidates, ALG.APV-527 and APVO603, were developed using ADAPTIR modular protein technology platform. The versatile and robust ADAPTIR and ADAPTIR-FLEX platforms are designed to generate monospecific, bispecific, and multi-specific antibody candidates that are capable of enhancing the human immune system against cancer cells.

Share on Social Networks: